Cargando…
Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients
Information on the role of radiotherapy in anti-PD-1 monoclonal antibody-treated melanoma patients is limited. We report on a prospective cohort of advanced melanoma patients treated simultaneously with radiotherapy and anti-PD-1 therapy between 01/01/15 and 30/06/16. Tumor evaluations (RECIST 1.1)...
Autores principales: | Roger, Anissa, Finet, Adeline, Boru, Blandine, Beauchet, Alain, Mazeron, Jean-Jacques, Otzmeguine, Yves, Blom, Astrid, Longvert, Christine, de Maleissye, Marie-Florence, Fort, Magali, Funck-Brentano, Elisa, Saiag, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053300/ https://www.ncbi.nlm.nih.gov/pubmed/30034949 http://dx.doi.org/10.1080/2162402X.2018.1442166 |
Ejemplares similares
-
Efficacy of Large Use of Combined Hypofractionated Radiotherapy in a Cohort of Anti-PD-1 Monotherapy-Treated Melanoma Patients
por: Saiag, Philippe, et al.
Publicado: (2022) -
Impact du confinement lié au COVID-19 sur le retard au diagnostic et la sévérité du mélanome
por: Molinier, Rafaele, et al.
Publicado: (2021) -
Variation of mutant allele frequency in NRAS Q61 mutated melanomas
por: Hélias-Rodzewicz, Zofia, et al.
Publicado: (2017) -
Cutaneous toxicities from targeted therapies used in oncology: Literature review of clinical presentation and management
por: Huynh Dagher, Solène, et al.
Publicado: (2021) -
Ketamine as Monotherapy in Difficult Airways Is Not Ready for Prime Time
por: Driver, Brian E., et al.
Publicado: (2019)